Clinical trials
Phase 2 Major Depressive Disorder trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Seaport Therapeutics | 2 |
| Affectis Pharmaceuticals AG | 1 |
| Bristol-Myers Squibb | 1 |
| Draig Therapeutics Ltd | 1 |
| GH Research Ireland Limited | 1 |
| H. Lundbeck A/S | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Neurocrine Biosciences | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 13 |
| Depressive Disorder | 4 |
| Mood Disorders | 4 |
| Anxiety Disorders | 2 |
| Mental Disorders | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Multiple Sclerosis | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.